Skip to content

What Medications Can Lead to Gallstones? A Guide to Drug-Induced Cholelithiasis

4 min read

Gallstones affect millions of individuals, and while diet and genetics are well-known risk factors, certain medications are a recognized, though less common, cause of cholelithiasis. This article explores what medications can lead to gallstones, explaining the pharmacological mechanisms and outlining the most common culprits.

Quick Summary

This guide covers several medication classes linked to gallstone formation, including hormones, certain antibiotics, and somatostatin analogs, by explaining how they disrupt bile or gallbladder function. It details specific drugs and their associated risks.

Key Points

  • Hormonal Therapies: Oral estrogen and progesterone therapies can increase cholesterol secretion into bile and reduce gallbladder motility, raising the risk of gallstones.

  • Somatostatin Analogs: Long-term use of drugs like octreotide significantly increases gallstone risk by causing gallbladder stasis and altering bile absorption.

  • Fibrate Cholesterol Drugs: Unlike statins, fibrates such as gemfibrozil and fenofibrate can increase the amount of cholesterol in bile, promoting cholesterol gallstone formation.

  • Ceftriaxone Antibiotic: High or prolonged doses can cause reversible 'pseudolithiasis' from drug-calcium salt precipitates in the bile.

  • Atazanavir HIV Medication: This antiviral can directly precipitate in the bile, forming gallstones that are rich in the drug itself.

  • GLP-1 Agonists: Medications like liraglutide used for diabetes or obesity may increase the risk of gallbladder disease, as noted in recent studies.

  • Management: If drug-induced gallstones are suspected, discontinuing the causative medication is often the first step, with some types of stones resolving spontaneously.

In This Article

Understanding Gallstone Formation

Gallstones are hard, pebble-like deposits that form inside the gallbladder, a small organ beneath the liver. The two main types are cholesterol stones and pigment stones. Cholesterol stones, which are the most common in Western countries, form when bile contains too much cholesterol and not enough bile salts to keep it dissolved. Pigment stones are less common and are made of bilirubin and calcium.

Medications can promote gallstone formation through a few primary mechanisms:

  • Altering bile composition: Some drugs increase the amount of cholesterol secreted into bile or decrease bile salt concentrations, tipping the balance toward crystal formation.
  • Reducing gallbladder motility: A sluggish or less mobile gallbladder can cause bile to stagnate, allowing more time for crystals to grow into stones.
  • Drug precipitation: In some cases, the drug itself can crystallize and precipitate in the bile, forming a physical nidus for a stone.

Medications That Increase Gallstone Risk

Hormonal Therapies

Both oral contraceptives (OCs) and hormone replacement therapy (HRT) are known risk factors for gallstones, particularly in women. The hormonal components, primarily estrogen, play a crucial role.

  • Estrogen: This hormone increases the amount of cholesterol secreted into the bile by the liver, making it more saturated with cholesterol and more likely to form stones.
  • Progestin: Progesterone and its synthetic form, progestin, can decrease the motility of the gallbladder, leading to bile stasis. This stagnation allows more time for cholesterol crystals to form and accumulate.

Oral administration of these hormones carries a higher risk than transdermal (patch or gel) delivery because oral administration leads to a 'first-pass' effect, where the liver is exposed to higher concentrations of the hormone. The risk is also dose-dependent and increases with the duration of use. Newer, low-dose oral contraceptives carry a significantly lower risk than older, higher-dose formulations.

Somatostatin Analogs

These drugs are used to treat conditions like acromegaly and certain neuroendocrine tumors.

  • Octreotide (Sandostatin): A well-known somatostatin analog that can cause gallbladder stasis by inhibiting the release of cholecystokinin (CCK), a hormone that stimulates gallbladder contraction. Long-term use can result in gallstone formation in up to 50% of patients within a year.
  • Lanreotide (Somatuline Depot): Another somatostatin analog with a similar risk profile.

Lipid-Lowering Medications (Fibrates)

While statins are generally considered to potentially lower gallstone risk, another class of cholesterol-lowering drugs, fibrates, has the opposite effect.

  • Gemfibrozil (Lopid) and Fenofibrate (Tricor): These medications work by reducing triglycerides but also boost the amount of cholesterol secreted into the bile, making it more likely to form cholesterol stones.

Certain Antibiotics

Some antibiotics can cause temporary or reversible gallstones, a condition sometimes called "pseudolithiasis".

  • Ceftriaxone: This injectable cephalosporin antibiotic is excreted in the bile and can bind with calcium, forming insoluble calcium-ceftriaxone precipitates. These precipitates create biliary sludge or stones, which are often reversible after discontinuing the drug. The risk increases with higher doses or prolonged use.

HIV Medications

Some antiretroviral drugs used to treat HIV can cause stones by directly precipitating in the bile.

  • Atazanavir (Reyataz): This protease inhibitor can form stones that are primarily composed of the drug itself. Symptoms can appear after months or years of therapy and may require discontinuing the medication.

Type 2 Diabetes and Obesity Medications (GLP-1 Agonists)

Recent studies have identified an increased risk of gallbladder and bile duct diseases associated with GLP-1 receptor agonists.

  • Liraglutide (Victoza, Saxenda): This drug, along with others in its class, has been associated with a higher risk of bile duct and gallbladder disease, potentially through effects on gallbladder motility or bile composition.

Comparison of Drug-Induced Gallstone Risks

Medication Class Example(s) Primary Mechanism Typical Stone Type Incidence/Risk Profile
Hormonal Therapies (Oral) Oral Contraceptives, HRT (Estrogen/Progestin) Increased biliary cholesterol secretion; decreased gallbladder motility Cholesterol Higher risk with oral administration, high doses, and longer duration
Somatostatin Analogs Octreotide, Lanreotide Gallbladder stasis by inhibiting CCK release Often cholesterol-rich or mixed High incidence (~50% after 1 year)
Lipid-Lowering Drugs Gemfibrozil, Fenofibrate (Fibrates) Increased biliary cholesterol secretion Cholesterol Increased risk, conflicting with statins which may protect
Antibiotics Ceftriaxone Precipitation of drug-calcium salt in bile Calcium-ceftriaxone precipitates Reversible pseudolithiasis, higher risk with dose/duration
HIV Medications Atazanavir Drug precipitation in bile Atazanavir-rich stones Risk associated with long-term use
GLP-1 Agonists Liraglutide Impacts gallbladder motility and/or bile composition Often cholesterol stones Increased risk identified in recent studies

What to Do If You Suspect Drug-Induced Gallstones

If you are taking a medication and experience symptoms such as right upper abdominal pain, nausea, or vomiting, especially after a fatty meal, it is important to consult your healthcare provider. A medical professional can help determine if your medication is the cause. Management often involves a few key steps:

  • Diagnosis: Your doctor will likely use abdominal ultrasound or other imaging to confirm the presence of gallstones or biliary sludge.
  • Medication Review: Your provider will review your medication list and evaluate whether any prescribed drugs could be contributing to the problem. They may consider switching to an alternative medication if appropriate and safe.
  • Discontinuation and Monitoring: For reversible cases like ceftriaxone-induced pseudolithiasis, simply stopping the medication may be enough. These stones often dissolve on their own over weeks to months.
  • Surgery: If the gallstones are symptomatic and cause recurrent pain or complications like cholecystitis, surgery to remove the gallbladder (cholecystectomy) may be necessary.

Conclusion

While drug-induced gallstones are not the most common form of the condition, it is a significant side effect for certain medications. Hormonal therapies, somatostatin analogs, fibrates, and specific antibiotics are among the most frequently implicated classes. Understanding the mechanism—whether it's altering bile chemistry, slowing gallbladder movement, or direct precipitation—is key to managing the risk. It is important for patients and healthcare providers to be aware of this potential side effect to ensure prompt and appropriate diagnosis and management. Patients who suspect their medication is a factor should always discuss it with their doctor before making any changes to their treatment regimen. More information on medication side effects is available on the FDA's website, an authoritative source for drug safety.

Frequently Asked Questions

Medications that can cause gallstones include oral contraceptives, hormone replacement therapy, somatostatin analogs like octreotide, fibrate-type cholesterol-lowering drugs, and the antibiotic ceftriaxone.

Drugs cause gallstones primarily by altering bile composition (e.g., increasing cholesterol saturation), causing gallbladder stasis (sluggish emptying), or precipitating directly in the bile.

No, ceftriaxone-induced biliary sludge or stones, often called 'pseudolithiasis,' is typically reversible and resolves spontaneously after the medication is discontinued.

Oral contraceptives containing estrogen increase cholesterol secretion into bile, making it more prone to forming stones. Additionally, progestins can slow down gallbladder motility, causing bile to pool.

Unlike fibrates, which can increase the risk, some evidence suggests that long-term use of statins may actually reduce the risk of developing gallstones.

Symptoms of drug-induced gallstones are the same as non-drug related ones, and may include right upper abdominal pain, nausea, vomiting, or jaundice.

For certain medications like octreotide, preventative monitoring may be suggested. For others, a lower dose or a different route of administration may lower risk. Discussing the risks with your doctor is the best prevention strategy.

You should contact your healthcare provider immediately. They can help evaluate your symptoms, determine if your medication is the cause, and decide on the appropriate management plan, which may include observation, discontinuing the drug, or other treatment.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.